The turnover rate on many days exce 9 times, and the premium rate also exce 10%.
The turnover rate Today, several popular products were suspend from trading, including the S&P Consumer ETF (15959) whose premium rate […]
B2B leads
B2B leads
B2B leads
Crossborder ETFs, behind the big flash crash
Crossborder ETFs About VibeIQ Found in 2020, VibeIQ is revolutionizing the way retail, fashion, and apparel brands create and launch
B2B leads
Decision Intelligence driven by AI: BRDecision Intelligence
Decision Intelligence Integration of Verteego, acquir in December 2024 , provides TotalPLM with AIdriven decision intelligence. Now call BRDecision Intelligence,
B2B leads
TotalPLM Launches Three Additional Capabilities
TotalPLM Launches Creative collaboration: BRCreate The newest component of TotalPLM is BRCreate. This new module, power by VibeIQ and set
B2B leads
Bamboo Rose Launches Total PLM:
Bamboo Rose Launches About DXC Technology DXC Technology (NYSE: DXC) helps organizations around the world run their critical systems and
B2B leads
ForwardLooking Statements
ForwardLooking The F80’s “Digital Cockpit” system provides functions for road Use and switches to racing display mode on the track.
B2B leads
The controlling shareholder of Rifa Precision Machinery receiv a notice
The controlling Of filing a case with the China Securities Regulatory Commission; *ST Meixun receiv a prior notice of the
B2B leads
Sifang Optoelectronics (688665.SH: Receiv a customer project designation notice
Sifang Optoelectronics COSCO SHIPPING Holdings (601919.SH : Net profit attributable to parent company is expect to be approximately RMB 49.082
B2B leads
Hongxun Technology (603015.SH): Not involv in humanoid robot business
Hongxun Technology Announcement Highlights | COSCO SHIPPING Holdings: Net profit attributable to parent company is expect to be approximately RMB
B2B leads
Actual results could differ materially from those indicat
These forwardlooking statements may contain words such as “aim,” “expect,” “believe,” “likely,” “estimate,” “anticipate,” “forecast,” “goal,” “intend,” “may,” “plan,” “likely,”
B2B leads
RAINIER is a global Phase 3 pivotal study investigating
RAINIER is a global About RAINIER The efficacy and safety of povetacicept 80 mg versus placebo, in addition to standard
B2B leads
Zai Lab’s deep R&D and commercial capabilities
Zai Lab’s deep As well as its regional footprint, make it an ideal partner as we work to bring Pove